clonazepam has been researched along with physostigmine in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (44.44) | 18.7374 |
1990's | 1 (11.11) | 18.2507 |
2000's | 2 (22.22) | 29.6817 |
2010's | 2 (22.22) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bruno-Blanch, L; Gálvez, J; García-Domenech, R | 1 |
Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Barthuel, P; Ménini, C; Rektor, I; Silva-Barrat, C | 1 |
Bryere, P; Menini, C; Rektor, I; Silva-Barrat, C | 1 |
Bryére, P; Ménini, C; Naquet, R; Rektor, I; Silva-Barrat, C; Valin, A | 2 |
Lerer, B | 1 |
2 review(s) available for clonazepam and physostigmine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Alternative therapies for bipolar disorder.
Topics: Ascorbic Acid; Bipolar Disorder; Bupropion; Carbamazepine; Choline; Clonazepam; Clonidine; Clorgyline; Demeclocycline; Fenfluramine; Humans; Methylene Blue; Phosphatidylcholines; Physostigmine; Propiophenones; Propranolol; Spironolactone; Thyroxine; Tryptophan; Valproic Acid | 1985 |
7 other study(ies) available for clonazepam and physostigmine
Article | Year |
---|---|
Topological virtual screening: a way to find new anticonvulsant drugs from chemical diversity.
Topics: Anticonvulsants; Computer Simulation; Databases, Factual; Discriminant Analysis; Drug Design; Molecular Structure; Quantitative Structure-Activity Relationship | 2003 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Drugs influencing the GABAergic neurotransmission have no effect on the non-epileptic myoclonus of baboons.
Topics: Animals; Anticonvulsants; Benzodiazepines; Clonazepam; Female; gamma-Aminobutyric Acid; Male; Myoclonus; Papio; Photic Stimulation; Physostigmine; Synaptic Transmission | 1991 |
Stimulus-sensitive myoclonus of the baboon Papio papio: pharmacological studies reveal interactions between benzodiazepines and the central cholinergic system.
Topics: Animals; Atropine; Benzodiazepines; Benzodiazepinones; Clonazepam; Drug Interactions; Flumazenil; Myoclonus; Neostigmine; Papio; Parasympathetic Nervous System; Physostigmine; Quinuclidinyl Benzilate | 1986 |
[Type B myoclonus in Papio papio: results of the central anticholinergic effect of benzodiazepines].
Topics: Animals; Atropine; Benzodiazepines; Clonazepam; Electroencephalography; Myoclonus; Papio; Parasympathetic Nervous System; Parasympatholytics; Physostigmine | 1987 |
Physostigmine antagonizes benzodiazepine-induced myoclonus in the baboon, Papio papio.
Topics: Animals; Atropine; Benzodiazepinones; Clonazepam; Drug Synergism; Myoclonus; Papio; Parasympatholytics; Physostigmine | 1984 |